{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-042670","form_type":"8-K","ticker":"LTRN","cik":"0001763950","company_name":"Lantern Pharma Inc.","filed_at":"2023-11-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.354069+00:00","generated_at":"2026-06-07T21:54:40.777827+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Lantern Pharma to repurchase 145K shares from Bios Entities at $3.44/share","bullets":["Company agreed to buy 145,348 common shares from Bios Fund I entities at $3.44/share, total ~$500K.","Bios Entities own ~14.7% of outstanding shares; sale for their own working capital and liquidity.","Transaction expected to close by November 30, 2023; customary reps, warranties, and covenants.","Buyback represents about 0.5% of shares outstanding (based on recent filings)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-042670","json":"https://secwatch.observer/filing/0001493152-23-042670.json","markdown":"https://secwatch.observer/filing/0001493152-23-042670.md","text":"https://secwatch.observer/filing/0001493152-23-042670.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1763950/000149315223042670/0001493152-23-042670-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1763950/000149315223042670/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T21:54:40.777827+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}